Completed

Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Aortic Valve Disease+43

+ Laminopathies

+ Urogenital Diseases

See all eligibility criteria
How is the trial designed

Observational
Study Start: May 1992
See protocol details

Summary

Principal SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: May 10, 1992

Actual date on which the first participant was enrolled.

The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.

NCT00001313
Principal SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Aortic Valve DiseaseLaminopathiesUrogenital DiseasesAngina PectorisAortic Stenosis, SubvalvularAortic Valve StenosisArterial Occlusive DiseasesArteriosclerosisCardiovascular DiseasesEndocrine System DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsCardiomegalyHeart Valve DiseasesHypertensionKidney DiseasesLung DiseasesMetabolic DiseasesCardiomyopathiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurologic ManifestationsNutritional and Metabolic DiseasesPainRespiratory Tract DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsUrologic DiseasesVascular DiseasesPeripheral Vascular DiseasesMyocardial IschemiaGenetic Diseases, InbornGlucose Metabolism DisordersAtherosclerosisFemale Urogenital DiseasesMale Urogenital DiseasesCardiomyopathy, DilatedCardiomyopathy, HypertrophicChest PainCoronary Artery DiseaseCoronary DiseaseDiabetes MellitusHeart DiseasesHeart FailureHypertension, PulmonaryRenal Artery ObstructionMicrovascular AnginaPeripheral Arterial Disease

Criteria

INCLUSION CRITERIA: The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol: Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing. Cardiomyopathies including congestive phenotypes. Peripheral artery disease with intermittent claudication or limb-threatening ischemia. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy. Upper extremity peripheral artery disease. Diabetes with heart failure. Pulmonary hypertension. EXCLUSION CRITERIA: Pregnancy, for those patients who require catheterization-based diagnostics. Inability to provide informed consent.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Suburban Hospital

Bethesda, United StatesOpen Suburban Hospital in Google Maps

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, United States
Completed2 Study Centers